Andere talen Optimi Health Corp.

Aandelen

OPTI

CA68405H1001

Vertraagde tijd Canadian Securities Exchange Andere beurzen 21:39:56 15-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,37 ^CAD	+2,78%		-2,63%	+51,02%

14/05	Optimi Health ontvangt analysecertificaat voor Mdma 40Mg en 60Mg Gmp-capsules	CI
23/04	Optimi Health en Kwantlen Polytechnic University Applied Genomics Centre werken samen om de wetenschap en het onderzoek naar paddenstoelen te bevorderen	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules	14/05
Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules	14/05
Optimi Health Receives Certificate of Analysis for Mdma 40Mg and 60Mg Gmp Capsules	14/05
Optimi Health Provides Corporate Update	10/05
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research	09/05
Optimi Health Corp. Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research	09/05
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research	23/04
Optimi Health and Kwantlen Polytechnic University Applied Genomics Centre Partner to Advance Mushroom Science and Research	23/04
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)	15/04
Optimi Health Achieves Milestone: Completes In-House Production of MDMA Active Pharmaceutical Ingredient (API)	15/04
Optimi Health Corp. Completes In-House Production of MDMA Active Pharmaceutical Ingredient	15/04
Optimi Health Signs Psilocybin Supply Agreement With New Zealand-Based Mātai Medical Research Institute	09/04
Optimi Health Corp. Signs Psilocybin Supply Agreement with Matai Medical Research Institute	09/04
Early Warning Press Release in Accordance with National Instrument 62-103	04/04
Optimi Health Receives Finished Product Test Results and Certificate Of Analysis for GMP Natural Psilocybin Extract	02/04
Optimi Health Corp. Receives Finished Product Test Results and Certificate of Analysis for GMP Natural Psilocybin Extract	02/04
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference	28/03
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference	28/03
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University	26/03
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University	26/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Optimi Health Corp.

Aandelen

OPTI

CA68405H1001

Andere talen

Filters